Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suspension of androgen deprivation in prostate cancer patients with high chromogranin A (CgA)
2009-011257-40Phase 3Terminated
- Sponsor
- San Luigi Gonzaga Hospital
- Start
- May 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of triptorelin and leuprolide in castration-resistant prostate cancer (CRPC) (2 arms), sponsored by San Luigi Gonzaga Hospital. Started May 2009; status: terminated.
02
Drugs
triptorelinleuprolide
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on 2009-011257-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011257-40.